BioCorRx Financial Statements From 2010 to 2024
BICX Stock | USD 0.30 0.06 16.67% |
Check BioCorRx financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among BioCorRx's main balance sheet or income statement drivers, such as , as well as many indicators such as . BioCorRx financial statements analysis is a perfect complement when working with BioCorRx Valuation or Volatility modules.
BioCorRx |
BioCorRx OTC Stock Shares Outstanding Analysis
BioCorRx's Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.
Current BioCorRx Shares Outstanding | 7.63 M |
Most of BioCorRx's fundamental indicators, such as Shares Outstanding, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, BioCorRx is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Outstanding shares that are stated on company Balance Sheet are used when calculating many important valuation and performance indicators including Return on Equity, Market Cap, EPS and many others.
Competition |
Based on the latest financial disclosure, BioCorRx has 7.63 M of shares currently outstending. This is 95.77% lower than that of the Healthcare sector and significantly higher than that of the Medical Care Facilities industry. The shares outstanding for all United States stocks is 98.67% higher than that of the company.
BioCorRx Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining BioCorRx's current stock value. Our valuation model uses many indicators to compare BioCorRx value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across BioCorRx competition to find correlations between indicators driving BioCorRx's intrinsic value. More Info.BioCorRx is number one stock in return on asset category among its peers. It also is number one stock in operating margin category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value BioCorRx by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for BioCorRx's OTC Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.About BioCorRx Financial Statements
BioCorRx investors use historical fundamental indicators, such as BioCorRx's revenue or net income, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in BioCorRx. Please read more on our technical analysis and fundamental analysis pages.
BioCorRx Inc., through its subsidiaries, develops and provides treatment programs for substance abuse and related disorders in the United States. The company was formerly known as Fresh Start Private Management, Inc. and changed its name to BioCorRx Inc. in January 2014. Biocorrx operates under Medical Care Facilities classification in the United States and is traded on OTC Exchange.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for BioCorRx OTC Stock Analysis
When running BioCorRx's price analysis, check to measure BioCorRx's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BioCorRx is operating at the current time. Most of BioCorRx's value examination focuses on studying past and present price action to predict the probability of BioCorRx's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BioCorRx's price. Additionally, you may evaluate how the addition of BioCorRx to your portfolios can decrease your overall portfolio volatility.